2022 MIT Technology Review’s EmTech: Flagship Founder & CEO Noubar Afeyan on Programmable Medicines

Flagship Founder & CEO Noubar Afeyan gives a talk about programmable medicines at EmTech 2022, MIT Technology Review’s annual gathering on emerging technology and global trends.

Video: MIT Technology Review’s EmTech MIT Conference